News
FDA extends the decision on Regenxbio's RGX-121 for Hunter syndrome to February 2026 following the submission of new ...
The extension was needed to review newly submitted long-term clinical data for all patients in the pivotal study following an FDA information request.
9h
Daily Times on MSNSecurity forces foil BLA terror plot involving professor
PM ...
The U.S. has designated the Balochistan Liberation Army a foreign terrorist organization and included the TTP in the ...
14h
The Express Tribune on MSNProfessor accused in foiled BLA terror plot
Security forces have foiled a major terrorist attack that was planned for August 14 by the proscribed Balochistan Liberation Army (BLA), implicating a university professor as facilitator."This was not ...
Pakistan’s security forces in the southwestern province of Balochistan have arrested a university lecturer accused of ...
Novavax, Inc. (NASDAQ:NVAX) is a biotechnology company focused on recombinant protein-based vaccines using nanoparticle and ...
Event highlights San Diego’s vital role in biotech innovation and UC San Diego’s commitment to research, patients and ...
In this Healio Video Perspective from the Retina World Congress, Huma Qamar, MD, MPH, of Ocugen, overviews programs for ...
The firm plans to submit CMC data for DTX401 informed by the FDA's observations related to an application for its Sanfilippo syndrome type A gene therapy.
Security forces in southwestern Pakistan have arrested a university lecturer accused of planning a foiled suicide attack ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results